Tf. Woolf et al., BIOACTIVATION AND IRREVERSIBLE BINDING OF THE COGNITION ACTIVATOR TACRINE USING HUMAN AND RAT-LIVER MICROSOMAL PREPARATIONS - SPECIES-DIFFERENCE, Drug metabolism and disposition, 21(5), 1993, pp. 874-882
Tacrine's [1,2,3,4-tetrahydro-9-acridinamine monohydrochloride monohyd
rate, (THA)] metabolic fate was examined using human and rat liver mic
rosomal preparations. Following 1-hr incubations with human microsomes
, [C-14]THA (0.4 muM) was extensively metabolized to 1-hydroxyTHA with
trace amounts of 2-, 4-, and 7-hydroxyTHA also produced. Poor recover
y of radioactivity in the postreaction incubates suggested association
of THA-derived radioactivity with precipitated microsomal protein. Af
ter exhaustive extraction, 0.034, 0.145, 0.126, and 0.012 nmol eq boun
d/mg protein/60 min of THA-derived radioactivity was bound to human li
ver preparations H109, H111, H116, and H118, respectively. Preparation
s H109 and H118 were lower in P4501A2 content and catalytic activity a
s compared with preparations H111 and H116. Incubations of equimolar [
C-14]1-hydroxyTHA with human liver microsomes also resulted in binding
to protein, although to a lesser extent than observed with THA. [C-14
]THA (0.4 muM) was incubated for 1 hr with rat liver microsomes (1 muM
P-450) prepared from noninduced (N), phenobarbital (PB), isoniazid (I
), and 3-methylcholanthrene (3-MC)-pretreated animals. In all incubati
ons, 1-hydroxyTHA was the major biotransformation product detected. Af
ter exhaustive extraction, 0.048, 0.054, 0.049, and 0.153 nmol eq/mg p
rotein/60 min of THA-derived radioactivity was bound to microsomal pro
tein from N, PB, I, and 3-MC pretreated rats. Increased binding with 3
-MC induced rat liver preparations suggests the involvement of the P-4
50 1A subfamily in THA bioactivation. Glutathione (5 mM) coincubation
inhibited the irreversible binding of THA-derived radioactivity in bot
h human and 3-MC-induced rat liver preparations, whereas human epoxide
hydrase (100 mug/incubate) had a relative minor effect. A mechanism i
s proposed involving a putative quinone methide(s) intermediate in the
bioactivation and irreversible binding of THA. A species difference i
n THA-derived irreversible binding exists between human and noninduced
rat liver microsomes, suggesting that the rat is a poor model for stu
dying the underlying mechanism(s) of THA-induced elevations in liver m
arker enzymes found in clinical investigations.